Trial intelligence / Profile preview

PTHrP(1-36) vs PTH(1-34) in Post-Menopausal Osteoporosis

NCT00853723Phase 2Completed

Sponsor
University of Pittsburgh
Start
May 2009
Primary completion
Feb 2012
Modality
Peptides
Countries
1
01

Overview

A Phase 2 trial of parathyroid hormone-related protein 1-36 in osteoporosis, sponsored by University of Pittsburgh. Started May 2009; status: completed.

02

Drugs

parathyroid hormone-related protein 1-36
03

Conditions

osteoporosis

Beyond the preview

Go deeper on NCT00853723.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00853723.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call